Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2010
08/10/2010US7772381 Efficient method to synthesize benzyl group-protected alpha-pentagalloylglucose (α-PGG) and its analogues
08/10/2010US7772371 blood disorders; administering lipidated Tissue Factor; hemorrhagic diathesis; thrombocytemia, polycytemia, chronic myelocytic leukemia, myeloid metaplasia, disproteinemias in scurvy, in congenital heart disease, and cirrhosis
08/10/2010US7772366 inflammation, autoimmune diseases, neurodegenerative diseases; a)hydrogen bonding moieties binding with a different backbone atom of ICE; b)hydrophobic moieties c)electronegative moiety; t-Butyl N-[(N-acetyl-O-t-butyltyrosinyl)-valaninyl-alaninyl]-3-amino-5-(2,6-dich- lorophenylmethyloxy)-4-oxo-pentanoat
08/10/2010US7772365 secreted tumor necrosis factor receptor polypeptides; modulates B cell activation; inhibiting ztnf4 activity
08/10/2010US7772272 Method for enhancing glucose uptake into warm-blooded animal adipocytes
08/10/2010US7772228 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori
08/10/2010US7772222 Reaction product of stimulant and ligand; central nervous system disorders
08/10/2010US7772217 For oral administering; mixture of polyunsaturated fatty acid, phospholipids, controller of methionine metabolism such as folic acid, vitamins, minerals, zinc
08/10/2010US7772208 Hepatitis C virus infections; beta -L-2',3'-dideoxy-5-fluorocytidine
08/10/2010US7772202 Methods for treating breast cancer using NRIF3 related molecules
08/10/2010US7772196 Skin disorders such as psoriasis or dermatitis; lipid or phospholipid moiety conjugates with monomers, oliogmers or polymers; e.g. phosphatidylethanolamine bound to carboxymethylcellulose, heparin, hyaluronic acid, polyethylene glycol, or polygeline
08/10/2010US7772189 drug delivery to liver tissue of a complex or conjugate of drug and polypeptide comprising the amino acid sequence of SEQ ID NO:61; biodrug is siRNA molecule
08/10/2010US7772188 Methods and compositions for the treatment of gastrointestinal disorders
08/10/2010US7772187 Substances directed against a specific sequence essential for heparanase catalytic activity and uses thereof as heparanase inhibitors
08/10/2010US7772185 applying a heparan sulfate proteoglycan-degrading enzyme; heparinase I, heparinase III, and heparanase;
08/10/2010US7772184 a cyclosporin having increased cyclophilin binding activity and lacking immunosuppressive activity; [D-MeAla]3-[EtVal]4-CsA (cyclic undecapeptide) in combination with one or both of an interferon alpha and ribavirin antiviral
08/10/2010US7772183 Hepatitis C virus inhibitors
08/10/2010US7772182 Stable suspension formulations of erythropoietin receptor agonists
08/10/2010US7772181 that target cytokines; greater activity; produced at greater yields; second protease inhibitory loop of BBPI scaffold is replaced with a binding peptide: VEGF binding peptide, fibroblast growth factor-5 (FGF) binding peptide, transforming growth factor beta (TGF) binding peptide, or TNF binding protein
08/10/2010US7772179 which binds to cell through ligand and activated by emitted light; photosensitizer is hematoporphyrin; transport ligand is peptide; conjugate of transferrin-hematoporphyrin which destroys cancerous cells in presence of luminol; tissue targeted
08/10/2010US7772178 Pharmaceutical formulations and methods of treatment using the same
08/10/2010US7772005 Non-surgical artificial insemination is achieved for sexed and unsexed equines in a commercially practical manner; insemination and sorting systems particularly adapted to use for sex-selected sperm
08/10/2010US7771996 FVII or FVIIa variants
08/10/2010US7771993 Microutrophin and uses thereof
08/10/2010US7771979 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
08/10/2010US7771978 Glycosyltransferase for use in enhancing glycospingolipid production in cells and treatment of brain disorders
08/10/2010US7771968 Gene upregulated in cancers of the prostate
08/10/2010US7771958 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors
08/10/2010US7771938 Nonlinear spectroscopic methods for identifying and characterizing molecular interactions
08/10/2010US7771931 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/10/2010US7771930 Identifying mutation in nucleotide sequences coding immunoglobulin domain carrying polypeptide for use in diagnosis and prognosis of cell proliferative disorders
08/10/2010US7771755 For therapy of bone disorders
08/10/2010US7771727 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
08/10/2010US7771724 Interfering with platelet adhesion by modulating the adhesion of amino acid residues at amino acid positions 560-566 of strand beta 3 of domain A1 of von Willebrand factor to amino acid residues at amino acid positions 227-242 of a region of platelet platelet-receptor glycoprotein Ib alpha (GpIb alpha)
08/10/2010US7771723 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
08/10/2010US7771721 Methods for using chimeric vascular endothelial growth factor receptor proteins
08/10/2010US7771714 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens
08/10/2010US7771711 Sphingolipids' polyalkylamines conjugates
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2451768C Peptoid compounds
08/10/2010CA2432175C Storage stable powder compositions of interleukin-4 receptor
08/10/2010CA2369457C Ocular treatment using cyclosporin-a derivatives
08/10/2010CA2361617C Uses of thank, a tnf homologue that activates apoptosis
08/10/2010CA2361238C Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/10/2010CA2319309C Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
08/10/2010CA2267095C Nucleotide and protein sequence of mammastatin and methods of use
08/10/2010CA2253239C Antibodies against interferon alpha/beta receptor
08/10/2010CA2235627C Receptor and nucleic acid molecule encoding said receptor
08/10/2010CA2223491C Cdr-grafted anti-tissue factor antibodies and methods of use thereof
08/10/2010CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
08/10/2010CA2180032C Gene expression control
08/10/2010CA2165969C Vertebrate apoptosis gene: compositions and methods
08/10/2010CA2124583C Synthetic compounds and compositions with enhanced cell binding
08/05/2010WO2010088573A1 Cyclosporin analogues for preventing or treating hepatitis c infection
08/05/2010WO2010088527A2 Peptides and nanoparticles for therapeutic and diagnostic applications
08/05/2010WO2010088415A2 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
08/05/2010WO2010088411A2 Conformationally dynamic peptides
08/05/2010WO2010088400A1 Methods of diagnosing and treating neurodegenerative diseases
08/05/2010WO2010088304A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010WO2010088300A1 Crystalline insulin-conjugates
08/05/2010WO2010088225A2 Regulation of mammalian keratinous tissue using skin and/or hair care actives
08/05/2010WO2010088160A1 T cell receptors and related materials and methods of use
08/05/2010WO2010087972A2 Il-1 binding proteins
08/05/2010WO2010087781A1 Polyelectrolyte complexes with bound peptides
08/05/2010WO2010087771A1 Compound and method for treatment of alzheimer's disease
08/05/2010WO2010087709A1 Alanine-glyoxylate aminotransferase therapeutics
08/05/2010WO2010087521A1 Combined preparation for treating joint diseases
08/05/2010WO2010087497A1 Pharmaceutical composition, and pharmaceutical preparation for treating tumors
08/05/2010WO2010087480A1 Pharmaceutical preparation or food containing peptide
08/05/2010WO2010087243A1 Adiponectin-containing eating behavior control agent for oral administration
08/05/2010WO2010086867A2 Peptides, pharmaceutical compositions comprising same and uses thereof
08/05/2010WO2010086709A1 Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
08/05/2010WO2010086530A1 Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
08/05/2010WO2010086512A2 Novel peptides and methods for producing them
08/05/2010WO2010086445A1 Tslp promotes immune evasion and persistence of viruses
08/05/2010WO2010086426A1 Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
08/05/2010WO2010086418A1 Functional food product comprising heat shock protein or a hydrolysate thereof
08/05/2010WO2010086384A1 Target for treatment of acute heart failure
08/05/2010WO2010086382A1 Target for treatment of acute heart failure
08/05/2010WO2010086070A1 Methods of treating bone disorders
08/05/2010WO2010086030A1 Container for pharmaceutical use for the quantitative release of a single dose for oral administration of t3 and t4 thyroid hormones in solution
08/05/2010WO2010085975A1 Pharmaceutical preparation comprising lipase of bacterial origin
08/05/2010WO2010066062A4 Basic fsh fraction for use as a cell-proliferation-controlling agent
08/05/2010WO2010066046A8 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
08/05/2010WO2010065954A3 Sparc binding peptides and uses thereof
08/05/2010WO2010056765A3 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
08/05/2010WO2010041913A3 Novel uses of grs proteins or fragments thereof
08/05/2010WO2010040147A9 Site-specific n-terminal modifications of proteins and conjugate formation
08/05/2010WO2010040000A3 A multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
08/05/2010WO2010025380A3 Analysis of hcv genotypes
08/05/2010WO2010005480A3 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
08/05/2010WO2009142773A3 Multivalent fibronectin based scaffold domain proteins
08/05/2010WO2009059298A8 Compositions and methods of enhancing immune responses to eimeria
08/05/2010WO2008091867A3 Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100199391 Anti-malaria vaccine compositions and uses thereof
08/05/2010US20100199368 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
08/05/2010US20100199367 Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
08/05/2010US20100199362 Wnt ligands involved in blood-brain barrier development and uses therefor
08/05/2010US20100199361 Role of Proteoglycans in Drug Dependence
1 ... 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 ... 3163